Real-time enrollment status for this gaucher disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:11 AM UTC
| NCT Number | NCT05487599 |
| Recruiting Status | Recruiting |
| Condition | Gaucher Disease |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Prevail Therapeutics |
| Last Updated on CT.gov | December 8, 2025 (Dec 8, 2025) |
As of March 2, 2026: Clinical trial NCT05487599 is currently recruiting participants. This clinical trial study for gaucher disease is actively seeking new participants at 3 locations across the United States. The study is sponsored by Prevail Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05487599 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05487599 was last updated Dec 8, 2025 (December 8, 2025). HelloStudys verifies this status automatically.